#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Drugs Covered: Methylphenidate and ritalinic acid.
Positive Cutoff: Methylphenidate: 1 ng/mL Ritalinic acid: 10 ng/mL The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
For medical purposes only; not valid for forensic use.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
80299
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Attenade (Methylphenidate & Metabolite - Confirmation/Quantitation - Urine), Concerta (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma), Daytrana (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma), Dexmethylphenidate (Methylphenidate & Metabolite - Confirmation/Quantitation - Urine), Focalin (Methylphenidate & Metabolite - Confirmation/Quantitation - Urine), Metadate (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma), Methylin (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma), Methylphenidate (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma), Pain Management (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma), Ritalin (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma), Ritalinic Acid (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
*ExistCrossReferences>